typic
flu
season
england
wale
around
million
extra
consult
acut
respiratori
infect
excess
hospit
admiss
around
death
influenza
pandem
around
peopl
england
symptomat
infect
case
fatal
rate
death
per
case
observ
evid
major
cardiovascular
event
promin
mechan
death
link
influenza
excess
mortal
influenza
epidem
europ
usa
earli
inde
attribut
caus
influenza
heart
diseas
find
replic
contemporari
studi
stroke
also
appear
common
respiratori
infect
studi
suggest
influenza
may
precursor
incid
cardiovascular
event
remain
inconsist
literatur
sever
review
evalu
potenti
influenza
trigger
cardiovascular
event
articl
summaris
cardiovascular
manifest
influenza
describ
direct
effect
viru
myocardium
well
potenti
mechan
acut
coronari
syndrom
infect
exist
studi
shown
evid
influenza
may
associ
cardiovascular
diseas
cvd
publish
associ
addit
studi
focus
coronari
heart
diseas
less
known
stroke
heart
failur
hf
view
uncertainti
regard
associ
influenza
symptom
risk
cvd
conduct
systemat
review
quantifi
risk
myocardi
infarct
mi
hf
stroke
among
patient
record
influenza
symptom
select
studi
evalu
associ
influenza
advers
cardiovascular
outcom
includ
studi
design
place
restrict
definit
influenza
could
base
record
symptom
serolog
confirm
case
consid
mi
hf
stroke
cardiovascular
death
search
via
ovid
medlin
embas
incept
end
august
languag
limit
use
broad
index
search
term
influenza
flu
myocardi
infarct
acut
coronari
syndrom
ischem
heart
diseas
ischaem
heart
diseas
heart
failur
cardiac
failur
left
ventricular
impair
stroke
cerebrovascular
diseas
cerebrovascular
accid
cardiac
death
cardiovascular
death
cardiovascular
mortal
addit
relev
studi
identifi
check
bibliographi
includ
articl
two
review
csk
su
evalu
titl
abstract
studi
met
inclus
criteria
studi
clearli
meet
select
criteria
exclud
one
senior
author
ykl
check
potenti
inclus
full
report
avail
potenti
relev
studi
retriev
independ
check
elig
two
review
independ
extract
data
includ
studi
proforma
spreadsheet
cover
studi
design
studi
locat
characterist
particip
definit
influenza
outcom
ascertain
result
spreadsheet
data
check
complet
accuraci
senior
review
ykl
two
review
csk
su
independ
extract
number
event
denomin
sourc
paper
therebi
enabl
calcul
crude
unadjust
estim
risk
advers
event
among
patient
influenza
raw
result
avail
collect
result
adjust
risk
estim
adjust
rel
risk
odd
ratio
hazard
ratio
cardiovascular
event
influenza
differ
reconcil
arbitr
investig
senior
clinic
research
ykl
author
manuscript
contact
seek
inform
necessari
qualiti
includ
studi
evalu
use
risk
bia
assess
includ
ascertain
exposur
influenza
ascertain
select
cardiovascular
outcom
adjust
potenti
confound
overal
risk
bia
studi
deem
low
three
categori
satisfi
deem
moder
risk
bia
two
categori
satisfi
high
risk
bia
zero
one
categori
satisfi
evid
substanti
heterogen
studi
avail
use
funnel
plot
assess
public
bia
use
revman
nordic
cochran
centr
copenhagen
denmark
conduct
random
effect
use
invers
varianc
weight
approach
calcul
pool
assum
asymptot
converg
risk
ratio
proport
advers
outcom
low
evalu
adjust
unadjust
data
primari
studi
although
preferenti
use
adjust
data
avail
stratifi
main
analysi
base
measur
ascertain
influenza
eg
laboratori
serolog
test
base
clinic
present
suggest
ill
use
adjust
account
potenti
confound
differ
type
influenza
report
use
categori
largest
number
patient
statist
heterogen
assess
use
statist
valu
repres
moder
level
heterogen
statist
result
present
main
effect
confid
interv
ci
brace
unless
otherwis
specifi
identifi
studi
met
inclus
criteria
detail
studi
select
shown
figur
seven
studi
two
studi
two
cohort
studi
one
studi
total
particip
mean
age
four
studi
rang
year
median
age
rang
year
four
studi
percentag
male
patient
rang
detail
shown
tabl
studi
qualiti
assess
shown
tabl
method
ascertain
exposur
influenza
includ
use
questionnair
clinic
assess
review
patient
record
laboratori
test
seven
studi
use
method
ascertain
influenza
exposur
blood
test
lung
tissu
test
valid
algorithm
apart
one
studi
ascertain
outcom
unclear
studi
report
method
could
reliabl
identifi
cardiovascular
event
three
studi
report
use
adjust
two
potenti
confound
term
risk
bia
one
studi
classifi
low
risk
bia
three
studi
classifi
high
risk
bia
influenza
exposur
cardiovascular
outcom
evalu
result
shown
tabl
influenza
exposur
defin
serolog
laboratori
test
four
studi
five
studi
base
symptom
questionnair
madjid
et
al
influenza
epidem
defin
weekli
acut
respiratori
diseas
morbid
exceed
predefin
epidem
threshold
report
time
influenza
exposur
variabl
three
studi
report
inform
among
studi
influenza
exposur
rang
preced
week
preced
month
final
nine
studi
evalu
mi
cardiovascular
outcom
one
studi
evalu
death
mi
one
studi
evalu
ischaem
stroke
one
studi
evalu
hf
nine
studi
mi
outcom
exclud
studi
pesonen
et
al
sinc
compar
risk
mi
differ
influenza
symptom
level
rather
symptom
vs
symptom
remain
eight
studi
stratifi
four
studi
use
serolog
laboratori
test
confirm
influenza
seven
studi
diagnos
influenza
base
symptom
clinic
present
pool
risk
mi
serolog
diagnos
influenza
ci
particip
signific
studi
adjust
confound
ci
figur
pool
risk
mi
symptom
ci
particip
signific
unadjust
ci
five
studi
particip
adjust
ci
two
studi
particip
studi
see
figur
pesonen
et
al
found
two
three
vs
one
symptom
ill
associ
increas
risk
mi
ci
studi
nichol
et
al
studi
evalu
risk
hf
influenza
studi
found
three
eight
particip
test
posit
influenza
hf
left
ventricular
failur
congest
cardiac
failur
four
particip
hf
crude
risk
hf
studi
ci
studi
luna
et
al
evalu
time
ill
risk
ischaem
stroke
found
greatest
risk
present
within
first
day
adjust
ci
decreas
magnitud
prolong
durat
adjust
ci
day
madjid
et
al
conduct
studi
includ
evalu
outcom
indirectli
name
autopsi
rate
cvd
vs
influenza
epidem
studi
evalu
risk
cardiovascular
mortal
found
influenza
epidem
associ
increas
odd
death
acut
mi
ci
suggest
ill
associ
twofold
increas
mi
risk
mi
serolog
defin
influenza
less
evid
howev
studi
adjust
potenti
confound
show
increas
risk
mi
posit
influenza
test
addit
limit
evid
ill
precipit
stroke
hf
event
although
observ
base
singl
public
thu
warrant
studi
major
challeng
studi
associ
symptom
cvd
spectrum
viral
infect
initi
symptom
review
ill
suggest
respiratori
syncyti
viru
rhinoviru
adenoviru
parainfluenza
virus
human
coronavirus
present
similar
influenza
studi
ill
success
winter
uk
found
swab
posit
respiratori
syncyti
viru
smaller
studi
scotland
found
picornaviru
also
import
caus
ill
studi
also
identifi
rhinoviru
adenoviru
human
corona
viru
parainfluenza
viru
import
caus
ill
find
suggest
exposur
ill
may
associ
increas
risk
cardiovascular
event
henc
measur
influenza
vaccin
support
line
current
recommend
particularli
among
patient
risk
cvd
definit
influenza
vari
among
studi
current
analysi
sinc
serolog
test
clinic
assess
use
observ
ill
defin
clinic
featur
may
caus
influenza
viral
infect
highlight
associ
increas
risk
mi
associ
appear
absent
influenza
case
defin
serolog
number
possibl
explan
might
account
clinic
featur
influenza
may
secondari
viral
infect
use
clinic
featur
may
includ
infect
particip
influenza
diagnos
serolog
may
repres
differ
biolog
cohort
patient
influenza
diagnosi
base
clinic
featur
may
particip
identifi
serolog
may
asymptomat
atyp
milder
symptom
infect
less
virul
genotyp
influenza
viru
particip
diagnos
influenza
clinic
ground
might
sever
influenza
infect
could
manifest
cardiovascular
complic
inclus
asymptomat
case
may
lead
cohort
fewer
cardiovascular
event
reduc
likelihood
detect
differ
compar
control
group
second
time
serolog
test
import
determin
associ
cardiovascular
event
serolog
test
abl
measur
antibodi
develop
respons
influenza
viru
respons
develop
within
week
infect
develop
antibodi
remain
detect
level
month
thu
make
test
reliabl
confirm
influenza
infect
exposur
consequ
serolog
test
took
place
acut
phase
infect
test
result
may
repres
fals
neg
qualiti
serolog
test
influenza
may
also
present
problem
high
qualiti
standardis
method
use
minimis
variabl
result
notabl
two
studi
serolog
took
place
unclear
laboratori
test
reliabl
robust
conduct
recent
serolog
test
may
detect
antibodi
gener
previou
exposur
antigen
similar
virus
lead
fals
posit
result
current
gold
standard
laboratori
confirm
influenza
viru
infect
revers
chain
reaction
viral
cultur
although
methodolog
use
studi
includ
current
analysi
notabl
differ
influenza
ill
true
influenza
confirm
serolog
includ
mimic
unless
dual
infect
howev
serolog
defin
influenza
infect
also
includ
asymptomat
case
may
clinic
relev
may
miss
unless
studi
defin
cohort
test
particip
regardless
whether
symptomat
ill
hand
may
includ
viral
ill
previous
describ
popul
repres
clinic
relev
cohort
may
larger
true
influenza
cohort
howev
may
heterogen
clinic
featur
influenza
cohort
may
includ
infect
virus
ideal
studi
actual
consid
parallel
conduct
take
defin
popul
test
particip
influenza
prospect
collect
data
whether
particip
develop
symptom
influenza
studi
allow
understand
specif
ill
unclear
identifi
studi
cvd
patient
influenza
ill
built
exist
review
studi
first
quantifi
risk
consid
serolog
diagnosi
separ
symptomat
diagnos
review
limit
evid
risk
stroke
hf
ill
howev
mani
studi
low
qualiti
old
find
may
generalis
well
current
clinic
practic
set
found
evid
support
role
ill
trigger
cardiovascular
event
precis
mechan
unclear
suggest
influenza
ill
may
increas
risk
acut
mi
mechan
antigen
increas
cytokin
loss
properti
hdl
particl
increas
traffick
macrophag
arteri
wall
pronounc
express
inflammatori
cytokin
infect
monocyt
reduc
clot
time
induct
activ
infect
endotheli
cell
increas
express
tissu
factor
coagulopathi
inflamm
thought
key
factor
inflamm
also
import
part
atherosclerot
process
inflammatori
cytokin
increas
context
studi
influenza
mice
repeat
influenza
infect
may
injur
vascular
endotheli
cell
initi
inflammatori
respons
requir
acceler
enhanc
atherosclerosi
develop
furthermor
viral
infect
trigger
product
inflammatori
cytokin
could
destabilis
exist
vulner
plaqu
lead
mi
worth
note
includ
studi
high
risk
bia
retrospect
natur
studi
design
case
addit
bia
may
aris
variat
way
influenza
diagnos
rang
symptom
associ
respiratori
infect
diagnos
base
serolog
test
reliabl
diagnost
methodolog
laboratori
serolog
test
chest
infect
atyp
respiratori
infect
may
clinic
featur
consist
influenza
infect
howev
even
serolog
test
use
ascertain
influenza
infect
possibl
patient
serolog
posit
influenza
flu
may
account
dissimilar
two
larg
cohort
evalu
public
health
record
remain
studi
furthermor
adjust
potenti
confound
import
reduc
risk
bia
limit
number
studi
current
review
adjust
baselin
variabl
alway
risk
unmeasur
confound
report
bia
repres
limit
studi
includ
current
review
data
larg
databas
may
fail
captur
asymptomat
case
influenza
present
health
servic
patient
self
medic
seek
medic
attent
anoth
limit
relat
inclus
older
studi
use
differ
diagnost
criteria
mi
diagnost
criteria
mi
older
studi
base
mainli
clinic
criteria
echocardiographi
electrocardiograph
chang
possibl
enzym
rise
creatinin
kinas
sensit
high
sensit
troponin
assay
use
contemporari
practic
detect
myonecrosi
may
result
incid
mi
older
studi
studi
conduct
evalu
risk
cvd
influenza
observ
studi
prospect
design
outcom
link
cvd
regist
potenti
case
influenza
identifi
laboratori
test
perform
confirm
diagnosi
influenza
addit
import
potenti
confound
smoke
socioeconom
statu
underli
chronic
respiratori
diseas
cardiovascular
risk
factor
need
account
model
conclus
appar
associ
ill
advers
cardiovascular
event
associ
less
clear
serolog
defin
influenza
may
limit
publish
data
studi
design
mani
biolog
plausibl
mechan
explain
relationship
recommend
renew
effort
appli
current
clinic
guidelin
maximis
uptak
annual
influenza
immunis
among
patient
cvd
decreas
risk
mi
stroke
mam
conceptualis
review
csk
ykl
perform
literatur
search
csk
su
screen
search
result
relev
studi
extract
data
csk
ek
ykl
involv
csk
draft
manuscript
author
contribut
write
paper
